These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38622938)

  • 1. Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching.
    Kwon KT; Kim Y; Kim SW; Chang HH; Hwang S; Bae S; Nam E
    J Korean Med Sci; 2024 Apr; 39(14):e132. PubMed ID: 38622938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
    Zhou H; Buetti N; Pérez-Galera S; Bravo-Ferrer J; Gutiérrez-Gutiérrez B; Paniagua-García M; Feifel J; Sauser J; Kostyanev T; Canton R; Tan LK; Basoulis D; Pintado V; Roilides E; Dragovac G; Torre-Cisneros J; Mediç D; Akova M; Goossens H; Bonten M; Harbarth S; Rodriguez-Baño J; De Kraker MEA;
    J Antimicrob Chemother; 2024 Sep; 79(9):2132-2141. PubMed ID: 38988305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Risk Factors of Carbapenem-resistant
    Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
    J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
    Tan SH; Ng TM; Chew KL; Yong J; Wu JE; Yap MY; Heng ST; Ng WHW; Wan S; Cheok SJH; Tambyah PA; Lye DC
    Int J Antimicrob Agents; 2020 Feb; 55(2):105860. PubMed ID: 31841674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
    Lee GC; Lawson KA; Burgess DS
    Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
    Hassoun-Kheir N; Hussien K; Karram M; Saffuri M; Badaan S; Peleg S; Aboelhega W; Warman S; Alon T; Pollak D; Szwarcwort Cohen M; Paul M
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):129. PubMed ID: 37986092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Carbapenem-Resistant
    Rebold N; Lagnf AM; Alosaimy S; Holger DJ; Witucki P; Mannino A; Dierker M; Lucas K; Kunz Coyne AJ; El Ghali A; Caniff KE; Veve MP; Rybak MJ
    Microbiol Spectr; 2023 Feb; 11(1):e0264722. PubMed ID: 36622246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
    Moghnieh R; Abdallah D; Jadayel M; Zorkot W; El Masri H; Dib MJ; Omar T; Sinno L; Lakkis R; Jisr T
    Sci Rep; 2021 Jul; 11(1):14757. PubMed ID: 34285312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant
    Saito S; Hayakawa K; Tsuzuki S; Ishikane M; Nagashima M; Mezaki K; Sugiki Y; Tajima T; Matsunaga N; Ide S; Kinoshita N; Kusama Y; Fujitomo Y; Nakamoto T; Toda Y; Kaku M; Kodama EN; Ohmagari N
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33257451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study.
    Hoo GSR; Cai Y; Quek YC; Teo JQ; Choudhury S; Koh TH; Lim TP; Marimuthu K; Ng OT; Kwa AL
    Front Cell Infect Microbiol; 2022; 12():719421. PubMed ID: 35281438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence and expansion of carbapenem resistant enterobacterales in the Western Cape Province, South Africa.
    Moloto K; Newton-Foot M; Whitelaw A; Dramowski A
    PLoS One; 2024; 19(8):e0309315. PubMed ID: 39186516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.
    Alraddadi BM; Heaphy ELG; Aljishi Y; Ahmed W; Eljaaly K; Al-Turkistani HH; Alshukairi AN; Qutub MO; Alodini K; Alosaimi R; Hassan W; Attalah D; Alswaiel R; Saeedi MF; Al-Hamzi MA; Hefni LK; Almaghrabi RS; Anani M; Althaqafi A
    BMC Infect Dis; 2022 Jun; 22(1):542. PubMed ID: 35698046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease burden of bacteraemia with extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in Korea.
    Lee CM; Lee S; Kim ES; Kim HB; Park WB; Moon SM; Kim YK; Park KH; Kwak YG; Kim B; Kim YS; Kim CJ; Gil HY; Ahn J; Song KH
    J Hosp Infect; 2024 Feb; 144():85-93. PubMed ID: 38072088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.
    Bulens SN; Reses HE; Ansari UA; Grass JE; Carmon C; Albrecht V; Lawsin A; McAllister G; Daniels J; Lee YK; Yi S; See I; Jacob JT; Bower CW; Wilson L; Vaeth E; Lynfield R; Vagnone PS; Shaw KM; Dumyati G; Tsay R; Phipps EC; Bamberg W; Janelle SJ; Beldavs ZG; Cassidy PM; Kainer M; Muleta D; Mounsey JT; Laufer-Halpin A; Karlsson M; Lutgring JD; Walters MS
    Am J Infect Control; 2023 Jan; 51(1):70-77. PubMed ID: 35909003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.